Qalsody received the U.S. Food and Drug Administration's accelerated approval last year, but CMS said it found many Medicare ...
The Centers for Medicare & Medicaid Services (CMS) has mandated Medicare Advantage insurers to provide coverage for Biogen's amyotrophic lateral sclerosis (ALS) medication, Qalsody. This directive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback